[ Back to EurekAlert! ]

Contact: Cassandra Aviles
cmaviles@partners.org
617-724-6433
Massachusetts General Hospital

Ascites Tumor Cell (ATC) Chip

Caption: Ascites fluid from ovarian cancer patients is introduced through a filter into an inlet (left) where magnetically labeled benign cells are trapped. The remaining fluid passes through a microchip containing microwells where antibody-labeled tumor cells are captured (inset) for collection, imaging, and additional analyses.

Credit: Hakho Lee, PhD, and Jaehoon Chung, PhD, MGH Center for Systems Biology

Usage Restrictions: None

Related news release: Clinical waste may prove valuable for monitoring treatment response in ovarian cancer


[ Back to EurekAlert! ]